{
  "nctId": "NCT02911025",
  "briefTitle": "Effects of Clobazam on Sleep and Daytime Function in Patients With Epilepsy",
  "officialTitle": "Effects of Clobazam on Sleep and Daytime Function in Patients With Epilepsy",
  "protocolDocument": {
    "nctId": "NCT02911025",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2020-10-19",
    "uploadDate": "2021-02-05T14:46",
    "size": 122345,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT02911025/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [],
  "studyType": "OBSERVATIONAL",
  "enrollmentInfo": {
    "enrollmentCount": 13,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2015-01",
    "completionDate": "2017-12",
    "primaryCompletionDate": "2017-12",
    "firstSubmitDate": "2016-01-11",
    "firstPostDate": "2016-09-22"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* adults aged 18 years or older\n* diagnosis of epilepsy who are being considered for treatment with Clobazam\n\nExclusion Criteria:\n\n* known untreated moderate or severe sleep apnea\n* major circadian rhythm disorders",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Change in Sleep (Total Sleep Time) in Patients With Epilepsy Treated With Clobazam",
        "description": "The change in total sleep time in patients with epilepsy treat with clobazam one week after reaching effective clobazam dose",
        "timeFrame": "1 week after reaching effective clobazam dose"
      }
    ],
    "secondary": [
      {
        "measure": "Change in Sleep (Wake After Sleep Onset) in Patients With Epilepsy Treated With Clobazam",
        "description": "The change in wake after sleep onset (WASO) in patients with epilepsy treat with clobazam one week after reaching effective clobazam dose",
        "timeFrame": "1 week after reaching effective clobazam dose"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 1,
      "otherCount": 0,
      "totalCount": 2
    },
    "studyDesign": {
      "phases": [],
      "isRandomized": false,
      "isMasked": true
    },
    "overallComplexityScore": 34,
    "complexityCategory": "Moderate"
  },
  "collectionDate": "2025-09-22T02:29:49.604Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}